International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 1 , Pages 225-234, 1 September 2009

Modulation of Ionizing Radiation-Induced G2 Arrest by Cyclooxygenase-2 and its Inhibitor Celecoxib

  • Hyun Jung Jun, M.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
  • ,
  • Young Mee Kim, Ph.D.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
  • ,
  • Soo Yeon Park, B.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
  • ,
  • Ji Sun Park, M.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • Massachusetts General Hospital Cancer Center and Department of Medicine, Harvard Medical School, Boston, MA
  • ,
  • Eun Jung Lee, M.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
  • ,
  • Shin Ae Choi, M.Sc.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
  • ,
  • Hongryull Pyo, M.D., Ph.D.

      Affiliations

    • Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Republic of Korea
    • Corresponding Author InformationReprint requests to: Hongryull Pyo, M.D., Ph.D., Research Institute and Hospital, National Cancer Center, 809 Madu-1-dong, ILsandong-gu, Goyang-si, Gyeonggi-do, 410-769, Republic of Korea. Tel: (+82) 31-920-1723; Fax: (+82) 31-920-0149

Received 3 January 2009; received in revised form 15 April 2009; accepted 23 April 2009.

Purpose

Prolongation or attenuation of ionizing radiation (IR)-induced G2-M arrest in cyclooxygenase-2 (COX-2) overexpressing or celecoxib-treated cells, respectively, has been previously observed. To better understand the molecular mechanisms involved, we investigated the molecules involved in G2 checkpoint pathways after treatment with IR ± celecoxib.

Methods and Materials

Various molecules in the G2 checkpoint pathways were investigated in HCT-116-Mock and -COX-2 cells. Western blot, reverse transcriptase polymerase chain reaction, confocal microscopy, and fluorescence activated cell sorter (FACS) analyses were performed to investigate whether expression and activity of the ataxia telangiectasia and rad3-related (ATR) could be modulated by COX-2 and its selective inhibitors.

Results

COX-2 overexpression increased expression and activity of ATR after IR exposure. Celecoxib downregulated ATR in all tested cell lines independent of COX-2 expression, but downregulation was greater in COX-2 overexpressing cells after cells were irradiated. Celecoxib pretreatment before radiation caused strongly inhibited G2 arrest.

Conclusions

COX-2 appears to prolong IR-induced G2 arrest by upregulating ATR. Celecoxib downregulated ATR preferentially in irradiated COX-2 overexpressing cells. Celecoxib may radiosensitize cancer cells by inhibiting G2 arrest through ATR downregulation.

COX-2, celecoxib, radiation, ATR, G2 arrest

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This work was supported by the National Cancer Center (Grant No. 0710380-2).

 H.J.J. is currently at the Department of Neurosurgery and Molecular Oncology Research Institute, Tuffs Medical Center, Boston, MA.

 Conflict of interest none.

PII: S0360-3016(09)00720-2

doi:10.1016/j.ijrobp.2009.04.086

International Journal of Radiation Oncology * Biology * Physics
Volume 75, Issue 1 , Pages 225-234, 1 September 2009